TrialInvestigational new drugs2024

PD-1 inhibitor combined with albumin paclitaxel and apatinib as second-line treatment for patients with metastatic gastric cancer: a single-center, single-arm, phase II study.

Miaomiao Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.